Obesity

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

Close X
Other videos you might like

Recent Videos

Video

EASD 22: SURMOUNT-MMO: Tirzepatide in Obese Type II Diabetes Patients

Steven E Nissen,

Watch time: 07m 48s

Video Series

Dysphagia and the Management of Patients in Need of Lipid-Lowering

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Watch time: 1h 6m (4 videos)

Video Series

e-SPACE CRM 2022

Andrew JS Coats, Stefan Anker,

Broadcast

Nocturnal Hypertension

Roland Asmar, Melanie Dunwell, Matthew Capehorn, et al

Video

SPLENDOR: Metabolic Surgery and Risk of MACE in NASH

Ali Aminian,

Video

RESPONSE-2: Long Term Outcomes of Lifestyle Programme in CAD Patients

Harald Thune Jorstad,

Impact of BMI and Type of Ablation Procedure on Atrial Fibrillation Recurrence in Japanese Patients

Journal of Asian Pacific Society of Cardiology 2022;1:e15.

Bariatric Surgery Supported With Transvalvular Pumps: New Strategy for Morbidly Obese Patients to Get to Heart Transplantation

Interventional Cardiology Review 2022;17(Suppl 1):25.

Obesity and Atrial Fibrillation: Epidemiology, Pathogenesis and Effect of Weight Loss

Arrhythmia & Electrophysiology Review 2021;10(3):159–64.

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease

European Cardiology Review 2020;15:e04.

Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis

European Cardiology Review 2020;15:e37.

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy

European Cardiology Review 2020;15:e45.

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence

European Cardiology Review 2019;14(1):60–1

Relationship Between Obstructive Sleep Apnoea and AF

Arrhythmia & Electrophysiology Review 2019;8(3):180–3.

Obesity and Weight Loss

European Cardiology Review 2018;13(2):93–4.

Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities

Arrhythmia & Electrophysiology Review 2019;8(1):28–36.

Left Ventricular Remodelling: A Problem in Search of Solutions

European Cardiology Review 2016;11(1):29–35

What is Takotsubo (Stress) Cardiomyopathy?

European Cardiology Review 2015;10(1):6–8

Foreword

US Cardiology, 2006;3(1):11

How Do We Approach Low High-density Lipoprotein Cholesterol in 2011?

European Cardiology 2011;7(4):257–63

American Heart Association's Shared Focus is Critical to Achieving its Goals Faster

US Cardiology 2005;2(1):18–9

Excess Body Weight and Coronary Artery Disease - Associated Risks, the Obesity Paradox, and Implications for Cardiac Rehabilitation

US Cardiology 2011;8(2):88–93

The Million Hearts Initiative - Targeting Key Drivers of Cardiovascular Mortality from a Medical Specialty Society Perspective

US Cardiology 2012;9(1):66-70

Biomarkers Associated with Cardiometabolic Risk in Obesity

American Heart Hospital Journal 2011;9(1):28-32

High Prevalence of Obesity in Young Patients with ST Elevation Myocardial Infarction

American Heart Hospital Journal 2011;9(1):37-40

Tackling Childhood Obesity as a Strategy in Cardiovascular Risk Reduction

European Cardiology 2011;7(3):160–3